[go: up one dir, main page]

AU2003218168A8 - Ophthalmic solutions for delivery of expression vectors - Google Patents

Ophthalmic solutions for delivery of expression vectors

Info

Publication number
AU2003218168A8
AU2003218168A8 AU2003218168A AU2003218168A AU2003218168A8 AU 2003218168 A8 AU2003218168 A8 AU 2003218168A8 AU 2003218168 A AU2003218168 A AU 2003218168A AU 2003218168 A AU2003218168 A AU 2003218168A AU 2003218168 A8 AU2003218168 A8 AU 2003218168A8
Authority
AU
Australia
Prior art keywords
delivery
expression vectors
ophthalmic solutions
ophthalmic
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003218168A
Other versions
AU2003218168A1 (en
Inventor
Erlinda M Gordon
Frederick L Hall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of AU2003218168A1 publication Critical patent/AU2003218168A1/en
Publication of AU2003218168A8 publication Critical patent/AU2003218168A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2003218168A 2002-03-15 2003-03-14 Ophthalmic solutions for delivery of expression vectors Abandoned AU2003218168A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36478702P 2002-03-15 2002-03-15
US60/364,787 2002-03-15
PCT/US2003/007918 WO2003077796A2 (en) 2002-03-15 2003-03-14 Ophthalmic solutions for delivery of expression vectors

Publications (2)

Publication Number Publication Date
AU2003218168A1 AU2003218168A1 (en) 2003-09-29
AU2003218168A8 true AU2003218168A8 (en) 2003-09-29

Family

ID=28041960

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003218168A Abandoned AU2003218168A1 (en) 2002-03-15 2003-03-14 Ophthalmic solutions for delivery of expression vectors

Country Status (2)

Country Link
AU (1) AU2003218168A1 (en)
WO (1) WO2003077796A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0712987A2 (en) 2006-06-21 2012-04-10 Musc Found For Res Dev h-factor-targeted disease treatment
US9132193B2 (en) 2012-11-05 2015-09-15 University of Pittsburgh—of the Commonwealth System of Higher Education Use of Slurp1 as an imunomodulatory molecule in the ocular surface
SI2968461T1 (en) 2013-03-13 2023-01-31 Genzyme Corporation Fusion proteins comprising pdgf and vegf binding portions and methods of using thereof
WO2017070491A1 (en) * 2015-10-23 2017-04-27 Applied Genetic Technologies Corporation Ophthalmic formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827702A (en) * 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
WO1997040839A1 (en) * 1996-04-26 1997-11-06 Merck & Co., Inc. Dna vaccine formulations
CA2322232A1 (en) * 1998-03-13 1999-09-16 American Home Products Corporation Lyophilized polynucleotide composition, method of preparation, and uses thereof

Also Published As

Publication number Publication date
WO2003077796A3 (en) 2004-05-21
AU2003218168A1 (en) 2003-09-29
WO2003077796A2 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
AU2003211103A1 (en) Intracellular delivery of therapeutic agents
AU150583S (en) Eyeglasses
AU155116S (en) Sunglasses
AU151212S (en) Eyeglasses
AU150584S (en) Eyeglasses
IL176043A0 (en) Heterocyclic anti-migraine agents
AU150582S (en) Eyeglasses
AU2003299634A8 (en) Eyeglass frames
AU154626S (en) Eyeglasses
AU151436S (en) Eyeglasses
AU151211S (en) Eyeglasses
HUP0401605A3 (en) Integrin inhibitors for the treatment of eye diseases
AU154627S (en) Eyeglasses
AU2003260689A1 (en) Delivery of ophthalmic lenses
EG24403A (en) Ophthalmic composition
AU2003272817A8 (en) Eyecup for glasses
AU2003284171A8 (en) Aqueous ophthalmic spray and method for delivery
EP1667633A4 (en) Polysaccharides for pulmonary delivery of active agents
AU2003297657A1 (en) Antifungal therapeutic agents
AU2002240942A1 (en) Improved delivery of benefit agents
AU2003218168A8 (en) Ophthalmic solutions for delivery of expression vectors
PL397023A1 (en) Therapeutic agent for AIDS treatment
AU2003288476A1 (en) Device for ocular delivery of active principles by the transpalpebral route
EP1586324A4 (en) Ophthalmic therapeutic composition
IL163762A0 (en) Ophthalmic solutions containing tetrazole derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase